BRPI0520568A2 - uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv - Google Patents

uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv

Info

Publication number
BRPI0520568A2
BRPI0520568A2 BRPI0520568-9A BRPI0520568A BRPI0520568A2 BR PI0520568 A2 BRPI0520568 A2 BR PI0520568A2 BR PI0520568 A BRPI0520568 A BR PI0520568A BR PI0520568 A2 BRPI0520568 A2 BR PI0520568A2
Authority
BR
Brazil
Prior art keywords
preparation
wall skeleton
cell wall
hpv infection
nocardia rubra
Prior art date
Application number
BRPI0520568-9A
Other languages
English (en)
Inventor
Ce Zhang
Yi Zhang
Xiaoming Hong
Guoying Zhang
Jian Zhao
Original Assignee
Shenyang Sun Bell Com Biopharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Sun Bell Com Biopharm filed Critical Shenyang Sun Bell Com Biopharm
Publication of BRPI0520568A2 publication Critical patent/BRPI0520568A2/pt
Publication of BRPI0520568B1 publication Critical patent/BRPI0520568B1/pt
Publication of BRPI0520568B8 publication Critical patent/BRPI0520568B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

USO DE ESQUELETO DE PAREDE CELULAR DE NOCARDIA RUBRA NA PREPARAçãO DE MEDICAMENTOS PARA INFECçãO ANTI-HPV. A presente invenção refere-se ao uso de Esqueleto de Parede Celular de Nocardia rubra, especialmente o novo uso do mesmo na preparação de medicamentos anti-HPV.
BRPI0520568A 2005-09-23 2005-11-23 uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv BRPI0520568B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2005101055337A CN1935262B (zh) 2005-09-23 2005-09-23 红色诺卡氏菌细胞壁骨架在制备抗人乳头瘤病毒药物的用途
CN200510105533.7 2005-09-23
PCT/CN2005/001977 WO2007033533A1 (fr) 2005-09-23 2005-11-23 Utilisation du squelette de paroi cellulaire de nocardia rubra en vue de produire des médicaments favorisant la résistance au virus du papillome humain (vph)

Publications (3)

Publication Number Publication Date
BRPI0520568A2 true BRPI0520568A2 (pt) 2009-05-19
BRPI0520568B1 BRPI0520568B1 (pt) 2019-10-08
BRPI0520568B8 BRPI0520568B8 (pt) 2021-05-25

Family

ID=37888528

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520568A BRPI0520568B8 (pt) 2005-09-23 2005-11-23 uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv

Country Status (9)

Country Link
US (1) US8460722B2 (pt)
EP (1) EP1938826B1 (pt)
JP (1) JP4854742B2 (pt)
KR (1) KR20080048542A (pt)
CN (1) CN1935262B (pt)
BR (1) BRPI0520568B8 (pt)
HK (1) HK1100533A1 (pt)
RU (1) RU2394586C2 (pt)
WO (1) WO2007033533A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526119A (zh) * 2010-12-23 2012-07-04 辽宁纳可佳生物制药有限公司 红色诺卡氏菌细胞壁骨架增强树突状细胞功能的方法
CN108295095A (zh) * 2017-01-11 2018-07-20 福建省山河药业有限公司 红色诺卡氏菌细胞壁骨架在制备治疗痤疮的药物/护肤品中的用途及其药物/护肤品组合物
WO2020182181A1 (zh) * 2019-03-14 2020-09-17 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗外阴白色病变中的用途
US20220193148A1 (en) 2019-04-24 2022-06-23 Liaoning Greatest Bio-Pharmaceutical Co. Ltd. Use of nocardia rubra cell wall skeleton in treatment of thermal injury
WO2021147900A1 (zh) 2020-01-21 2021-07-29 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在再生医学中的用途
CN115025128A (zh) * 2022-06-24 2022-09-09 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗宫颈病变中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
CN1094288A (zh) * 1993-04-23 1994-11-02 福建省微生物研究所 利用红色诺卡氏菌制造细胞壁骨架粉末的方法
JP4859341B2 (ja) 2001-07-19 2012-01-25 昭 林 ヒト免疫療法
CN1291725C (zh) * 2002-03-08 2006-12-27 沈阳胜宝康生物制药有限公司 用于治疗宫颈糜烂的红色诺卡氏菌细胞壁骨架制剂及其制法
ES2471241T3 (es) 2002-09-06 2014-06-25 Ucl Business Plc Células bacterianas completas como inmunomodulador
WO2005023277A1 (fr) 2003-09-05 2005-03-17 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. Composition a la base de squelettes de parois de cellules de nocardia rouge procede de preparation et son utilisation therapeutique pour traiter l'erosion cervicale
CN1879661B (zh) 2005-06-16 2012-06-20 辽宁纳可佳生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备抗真菌感染的药物中的用途
CN101073583A (zh) 2006-05-19 2007-11-21 沈阳胜宝康生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备药物中的用途

Also Published As

Publication number Publication date
KR20080048542A (ko) 2008-06-02
CN1935262A (zh) 2007-03-28
JP4854742B2 (ja) 2012-01-18
EP1938826A1 (en) 2008-07-02
RU2394586C2 (ru) 2010-07-20
EP1938826B1 (en) 2014-11-12
RU2008109165A (ru) 2009-10-27
CN1935262B (zh) 2010-12-29
BRPI0520568B1 (pt) 2019-10-08
JP2009508883A (ja) 2009-03-05
US8460722B2 (en) 2013-06-11
WO2007033533A1 (fr) 2007-03-29
US20090028973A1 (en) 2009-01-29
BRPI0520568B8 (pt) 2021-05-25
HK1100533A1 (en) 2007-09-21
EP1938826A4 (en) 2011-09-07

Similar Documents

Publication Publication Date Title
CL2009002206A1 (es) Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
AR106702A2 (es) Uso de un anticuerpo antagonista anti-ngf para la preparación de un medicamento
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
MX2010004576A (es) Derivados de pirimidina novedosos.
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
HN2006009000A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
ECSP099044A (es) Compuestos de pirimido fusionados
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
DOP2011000176A (es) Compuestos organicos
CL2006001266A1 (es) Formas solidas cristalinas i, ii, iii, iv y v de tigeciclina; procedimiento de preparacion de las formas cristalinas ii, iv y v; composicion farmaceutica que comprende las formas cristalinas; y su uso para tratar infecciones bacterianas.
BRPI0520568A2 (pt) uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv
ECSP077271A (es) Derivados de pirimidina
ATE386534T1 (de) Orale darreichungsform enthaltend probiotische bakterien
ECSP077259A (es) Derivados de pirimidina
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
BRPI0716495A2 (pt) (r,r)-fenoterol e análogos de (r,r)- ou (r,s)-fenoterol, uso dos mesmos na preparação de composição farmacêutica e composição farmacêutica compreendendo o referidos compostos.
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
ATE485261T1 (de) Salicylsäurederivate
CL2007001838A1 (es) Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
EP2826771A3 (en) Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
ECSP11010811A (es) Uso de dronedarona para la preparación de un medicamento para la prevención de ictus o ataque isquémico transitorio
WO2008073863A3 (en) Preparation and utility of substituted allylamines

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD. (CN) ; LIAONING NAKEJIA BIOPHARMACEUTICAL CO., LTD. (CN)

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD.

B25G Requested change of headquarter approved

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD.

B25D Requested change of name of applicant approved

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25K Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Owner name: LIAONING GREATEST BIO-PHARMACEUTICAL CO., LTD. (CN

Free format text: RETIFICADO O DESPACHO 25.4 PUBLICADO NA RPI 2508 DE 29/01/2019 SOB O ITEM (71).

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/11/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF